Document:

Exhibit 10.1

 

September
29, 2020

 

Vesper
Healthcare Acquisition Corp.

1819
West Avenue

Bay
2

Miami
Beach, FL 33139

 

Re:Initial
Public Offering

 

Ladies
and Gentlemen:

 

This
letter (the “Letter Agreement”) is being delivered to you in accordance with the Underwriting Agreement
(the “Underwriting Agreement”) entered into by and between Vesper Healthcare Acquisition Corp., a Delaware
corporation (the “Company”) and Goldman Sachs & Co. LLC and J.P. Morgan Securities LLC, as representatives (the
“Representatives”) of the several underwriters named in Schedule I thereto (the “Underwriters”),
relating to an underwritten initial public offering (the “IPO”) of the Company’s units (the “Units”),
each unit comprised of one share of the Company’s Class A common stock, par value $0.0001 per share (the “Common
Stock”), and one-third of one redeemable warrant, each whole warrant exercisable for one share of Common Stock (each,
a “Warrant”). Certain capitalized terms used herein are defined in paragraph 11 hereof.

 

In
order to induce the Company and the Underwriters to enter into the Underwriting Agreement and to proceed with the IPO, and in
recognition of the benefit that such IPO will confer upon the undersigned, and for other good and valuable consideration, the
receipt and sufficiency of which are hereby acknowledged, the undersigned hereby agrees with the Company as follows:

 

	1.	If
                                         the Company solicits approval of its stockholders of a Business Combination, the undersigned
                                         will vote all shares of Common Stock beneficially owned by him or her, whether acquired
                                         before, in or after the IPO, in favor of such Business Combination.

 

	2.	In
                                         the event that the Company does not complete a Business Combination within the time period
                                         set forth in the Company’s second amended and restated certificate of incorporation,
                                         as the same may be further amended from time to time (the “Charter”),
                                         the undersigned will, as promptly as possible, take all necessary actions to cause the
                                         Company to (i) cease all operations except for the purpose of winding up, (ii) as promptly
                                         as reasonably possible, but not more than 10 business days thereafter, redeem the IPO
                                         Shares, at a per-share price, payable in cash, equal to the aggregate amount then on
                                         deposit in the Trust Account, including interest earned on the Trust Account not previously
                                         released to the Company to pay its tax obligations, if any (less up to $100,000 of such
                                         net interest to pay dissolution expenses), divided by the number of then outstanding
                                         IPO Shares, which redemption will completely extinguish public stockholders’ rights
                                         as stockholders (including the right to receive further liquidation distributions, if
                                         any), and (iii) as promptly as reasonably possible following such redemption, subject
                                         to the approval of the Company’s remaining stockholders and the Company’s
                                         board of directors, dissolve and liquidate, subject in the cases of clauses (ii) and
                                         (iii) to the Company’s obligations under Delaware law to provide for claims of
                                         creditors and other requirements of applicable law. The undersigned hereby waives any
                                         and all right, title, interest or claim of any kind in or to any distribution of the
                                         Trust Account and any remaining net assets of the Company as a result of such liquidation
                                         with respect to the Founder Shares owned by the undersigned. However, if any of the undersigned
                                         have acquired IPO Shares in or after the IPO, they will be entitled to liquidating distributions
                                         from the Trust Account with respect to such IPO Shares in the event that the Company
                                         does not complete a Business Combination within the time period set forth in the Charter.
                                         The undersigned acknowledges and agrees that there will be no distribution from the Trust
                                         Account with respect to any Warrants, all rights of which will terminate on the Company’s
                                         liquidation.

 

    1

     

    

 

	3.	The
                                         undersigned acknowledges and agrees that prior to entering into a definitive agreement
                                         for a Business Combination with a target business that is affiliated with the undersigned
                                         or any other Insiders of the Company or their affiliates, such transaction must be approved
                                         by a majority of the Company’s independent directors and the Company must obtain
                                         an opinion from an independent investment banking firm, which is a member of the Financial
                                         Industry Regulatory Authority, or an independent accounting firm that such Business Combination
                                         is fair to the Company’s unaffiliated stockholders from a financial point of view.

 

	4.	None
                                         of the undersigned, any member of the family of any of the undersigned, or any affiliate
                                         of the undersigned will be entitled to receive and will not accept any compensation or
                                         other cash payment from the Company prior to, or for services rendered in order to effectuate,
                                         the completion of the Business Combination; provided that the Company shall be allowed
                                         to make the payments set forth in the Registration Statement adjacent to the caption
                                         “Prospectus Summary—The Offering—Limited payments to insiders.”

 

	5.	(a)	The undersigned agrees that the Founder Shares may not
be transferred, assigned or sold (except to certain permitted transferees as described in the Registration Statement or herein)
(the “Lockup”) until the earlier to occur of: (1) one year after the completion of a Business Combination
or (2) the date following the completion of the Company’s initial Business Combination on which the Company completes a
liquidation, merger, capital stock exchange or other similar transaction that results in all of the Company’s stockholders
having the right to exchange their shares of Common Stock for cash, securities or other property. Notwithstanding the foregoing,
if the closing price of the Company’s Common Stock equals or exceeds $12.00 per share (as adjusted for share splits, stock
capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing
at least 150 days after the Company’s initial Business Combination, the Founder Shares will be released from the Lockup.

 

		(b)	Notwithstanding
                                         the provisions set forth in paragraphs 5(a) and 5(c), during the period commencing on
                                         the effective date of the Underwriting Agreement and ending 180 days after such date,
                                         the undersigned will not, without the prior written consent of the Representatives pursuant
                                         to the Underwriting Agreement, (i) sell, offer to sell, contract or agree to sell, hypothecate,
                                         pledge, hedge or otherwise dispose of or agree to dispose of (or enter into any transaction
                                         that is designed to, or might reasonably be expected to, result in the disposition (whether
                                         by actual disposition or effective economic disposition due to cash settlement or otherwise)
                                         by the undersigned or any affiliate of the undersigned or any person in privity with
                                         the undersigned or any affiliate of the undersigned), directly or indirectly, including
                                         the filing (or participation in the filing) of a registration statement with the Securities
                                         and Exchange Commission (the “SEC”) in respect of, or establish
                                         or increase a put equivalent position or liquidate or decrease a call equivalent position
                                         within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended,
                                         (the “Exchange Act”) and the rules and regulations of the SEC
                                         promulgated thereunder with respect to, any other Units, shares of Common Stock, Founder
                                         Shares or Warrants or any securities convertible into, or exercisable, or exchangeable
                                         for, shares of Common Stock owned by it, him or her, (ii) enter into any swap or other
                                         arrangement that transfers to another, in whole or in part, any of the economic consequences
                                         of ownership of any Units, shares of Common Stock, Founder Shares, Warrants or any securities
                                         convertible into, or exercisable, or exchangeable for, shares of Common Stock owned by
                                         it, him or her, whether any such transaction is to be settled by delivery of such securities,
                                         in cash or otherwise, or (iii) publicly announce any intention to effect any transaction,
                                         including the filing of a registration statement, specified in clause (i) or (ii). The
                                         provisions of this paragraph will not apply (i) to the transfer of Founder Shares to
                                         any independent director appointed or elected to the Company’s board of directors
                                         before or after the IPO or (ii) if the release or waiver is effected solely to permit
                                         a transfer not for consideration and, in each case the transferee has agreed in writing
                                         to be bound by the same terms described in this Letter Agreement to the extent and for
                                         the duration that such terms remain in effect at the time of the transfer.

 

    2

     

    

 

		(c)	The
                                         undersigned agrees that until the Company completes an initial Business Combination,
                                         the undersigned’s Private Placement Warrants will be subject to the transfer restrictions
                                         described in the Private Placement Warrants Purchase Agreement relating to the undersigned’s
                                         Private Placement Warrants.

 

		(d)	Notwithstanding
                                         the provisions set forth in paragraphs 5(a) and (c), transfers, assignments and sales
                                         by the undersigned of the Founder Shares, Private Placement Warrants and shares of Common
                                         Stock issued or issuable upon the exercise of the Private Placement Warrants or conversion
                                         of the Founder Shares are permitted (i) to the Company’s officers or directors,
                                         any affiliates or family members of any of the Company’s officers or directors,
                                         to BLS Investor Group LLC, a Delaware limited liability company (the “Sponsor”),
                                         any members or partners of the Sponsor or their affiliates, any affiliates of the Sponsor,
                                         or any employees of such affiliates; (ii) in the case of an individual, by gift to a
                                         member of the individual’s immediate family or to a trust, the beneficiary of which
                                         is a member of one of the individual’s immediate family, an affiliate of such person
                                         or to a charitable organization; (iii) in the case of an individual, by virtue of laws
                                         of descent and distribution upon death of the individual; (iv) in the case of an individual,
                                         pursuant to a qualified domestic relations order; (v) by private sales or transfers made
                                         in connection with the completion of the Business Combination at prices no greater than
                                         the price at which the Founder Shares, Private Placement Warrants or shares of Common
                                         Stock, as applicable, were originally purchased; (vi) by virtue of the Sponsor’s
                                         organizational documents upon liquidation or dissolution of the Sponsor; (vii) to the
                                         Company for no value for cancellation in connection with the completion of the Business
                                         Combination; (viii) in the event of the Company’s liquidation prior to the completion
                                         of a Business Combination; or (ix) in the event of completion of a liquidation, merger,
                                         share exchange or other similar transaction which results in all of the Company’s
                                         stockholders having the right to exchange their shares of Common Stock for cash, securities
                                         or other property subsequent to the completion of a Business Combination; provided, however,
                                         that in the case of clauses (i) through (vi) these permitted transferees must enter into
                                         a written agreement agreeing to be bound by the restrictions herein. For the avoidance
                                         of doubt, the transfers of Founder Shares, Private Placement Warrants and shares of Common
                                         Stock issued or issuable upon the exercise of the Private Placement Warrants or conversion
                                         of the Founder Shares shall be permitted regardless of whether a filing under Section
                                         16(a) of the Exchange Act shall be required or shall be voluntarily made with respect
                                         to such transfers.

 

    3

     

    

 

		(e)	The
                                         undersigned acknowledges and agrees that if, in order to complete any Business Combination,
                                         the holders of Founder Shares or Private Placement Warrants are required to contribute
                                         back to the capital of the Company a portion of any such securities to be cancelled by
                                         the Company or transfer any such securities to third parties, the undersigned will contribute
                                         back to the capital of the Company or transfer to such third parties, at no cost, a proportionate
                                         number of Founder Shares or Private Placement Warrants, as applicable, pro rata with
                                         the other holders of Founder Shares or Private Placement Warrants, as applicable.

 

	6.	The
                                         undersigned agrees to be a director or officer of the Company, as applicable, until the
                                         earlier of the completion by the Company of an initial Business Combination, the liquidation
                                         of the Company, or his or her removal, death or incapacity. In the event of the removal
                                         or resignation of the undersigned as a director or officer (as applicable), the undersigned
                                         agrees that he or she will not, prior to the completion of the Business Combination,
                                         without the prior express written consent of the Company, (i) use for the benefit of
                                         the undersigned or to the detriment of the Company or (ii) disclose to any third party
                                         (unless required by law or governmental authority), any information regarding a potential
                                         target of the Company that is not generally known by persons outside of the Company,
                                         the Sponsor or their respective affiliates. The undersigned’s biographical information
                                         previously furnished to the Company and the Representatives is true and accurate in all
                                         material respects, does not omit any material information with respect to the undersigned’s
                                         background and contains all of the information required to be disclosed pursuant to Item
                                         401 of Regulation S-K, promulgated under the Securities Act of 1933, as amended. The
                                         undersigned’s FINRA Questionnaire previously furnished to the Company and the Representatives
                                         is true and accurate in all material respects. The undersigned represents and warrants
                                         that:

 

		(a)	He
                                         or she is not subject to, or a respondent in, any legal action for, any injunction, cease-and
                                         desist order or order or stipulation to desist or refrain from any act or practice relating
                                         to the offering of securities in any jurisdiction;

 

		(b)	He
                                         or she has never been convicted of or pleaded guilty to any crime (i) involving any fraud
                                         or (ii) relating to any financial transaction or handling of funds of another person,
                                         or (iii) pertaining to any dealings in any securities and he is not currently a defendant
                                         in any such criminal proceeding; and

 

		(c)	He
                                         or she has never been suspended or expelled from membership in any securities or commodities
                                         exchange or association or had a securities or commodities license or registration denied,
                                         suspended or revoked.

 

	7.	The
                                         undersigned has full right and power, without violating any agreement by which he or
                                         she is bound, to enter into this Letter Agreement and to serve as a director or officer
                                         of the Company, as applicable.

 

	8.	The
                                         undersigned hereby waives his or her right to exercise redemption rights with respect
                                         to any of the Company’s shares of Common Stock owned or to be owned by the undersigned,
                                         directly or indirectly, whether such shares be part of the Founder Shares or IPO Shares,
                                         and agrees that he or she will not seek redemption with respect to such shares (or sell
                                         such shares to the Company in any tender offer) in connection with (x) the consummation
                                         of a Business Combination or (y) any stockholder vote to approve an amendment to the
                                         Charter that would affect the substance or timing of the Company’s obligation to
                                         allow redemption in connection with the Business Combination or to redeem 100% of the
                                         shares of Common Stock if the Company has not completed a Business Combination within
                                         the time period set forth in the Charter or with respect to any other provisions relating
                                         to stockholders’ rights or pre-initial business combination activity.

 

    4

     

    

 

	9.	The
                                         undersigned hereby agrees to not propose, or vote in favor of, an amendment to Paragraph
                                         25(d) of the Charter prior to the completion of a Business Combination unless the Company
                                         provides public stockholders with the opportunity to redeem their shares of Common Stock
                                         upon such approval in accordance with such Paragraph 25(d) thereof.

 

	10.	This
                                         Letter Agreement shall be governed by and construed and enforced in accordance with the
                                         laws of the State of New York, without giving effect to conflicts of law principles that
                                         would result in the application of the substantive laws of another jurisdiction. The
                                         undersigned hereby (i) agrees that any action, proceeding or claim against him arising
                                         out of or relating in any way to this Letter Agreement shall be brought and enforced
                                         in the courts of the State of New York of the United States of America for the Southern
                                         District of New York, and irrevocably submits to such jurisdiction, which jurisdiction
                                         shall be exclusive and (ii) waives any objection to such exclusive jurisdiction and that
                                         such courts represent an inconvenient forum.

 

	11.	As
                                         used herein, (i) a “Business Combination” shall mean a merger,
                                         capital stock exchange, asset acquisition, stock purchase, recapitalization, reorganization
                                         or other similar business combination with one or more businesses or entities; (ii) “Insiders”
                                         shall mean all officers and directors, and the sponsor of the Company immediately prior
                                         to the IPO; (iii) “Founder Shares” shall mean all of the Class
                                         B Common Stock of the Company, par value $0.0001 per share, acquired by an Insider prior
                                         to the IPO; (iv) “IPO Shares” shall mean the shares of Common
                                         Stock issued in the Company’s IPO; (v) “Private Placement Warrants”
                                         shall mean the warrants that are being sold privately by the Company simultaneously with
                                         the consummation of the IPO; (vi) “Trust Account” shall mean
                                         the trust account into which the net proceeds of the Company’s IPO and a portion
                                         of the proceeds from the sale of the Private Placement Warrants will be deposited; and
                                         (vii) “Registration Statement” means the Company’s registration
                                         statement on Form S-1 (SEC File No. 333-248717) filed with the SEC, as amended.

 

	12.	This
                                         Letter Agreement constitutes the entire agreement and understanding of the parties hereto
                                         in respect of the subject matter hereof and supersedes all prior understandings, agreements,
                                         or representations by or among the parties hereto, written or oral, to the extent they
                                         relate in any way to the subject matter hereof or the transactions contemplated hereby.
                                         This Letter Agreement may not be changed, amended, modified or waived (other than to
                                         correct a typographical error) as to any particular provision, except by a written instrument
                                         executed by all parties hereto.

 

	13.	The
                                         undersigned acknowledges and understands that the Underwriters and the Company will rely
                                         upon the agreements, representations and warranties set forth herein in proceeding with
                                         the IPO. Nothing contained herein shall be deemed to render any Underwriter a representative
                                         of, or a fiduciary with respect to, the Company, its stockholders or any creditor or
                                         vendor of the Company with respect to the subject matter hereof.

 

	14.	This
                                         Letter Agreement shall be binding on the undersigned and such person’s respective
                                         successors, heirs, personal representatives and assigns. This Letter Agreement shall
                                         terminate on the earlier of (i) the completion of a Business Combination and (ii) the
                                         liquidation of the Company; provided, that such termination shall not relieve the undersigned
                                         from liability for any breach of this agreement prior to its termination. The parties
                                         hereto may not assign either this Letter Agreement or any of their rights, interests,
                                         or obligations hereunder without the prior written consent of the other party. Any purported
                                         assignment in violation of this paragraph shall be void and ineffectual and shall not
                                         operate to transfer or assign any interest or title to the purported assignee.

 

    5

     

    

 

	 	Sincerely,
	 	 	 
	 	By:
    	/s/
    Brenton L. Saunders
	 	 	Brenton
    L. Saunders
	 	 	 
	 	By:
    	/s/
    Manisha Narasimhan
	 	 	Manisha
    Narasimhan 
	 	 	 
	 	By:
    	/s/
    Barry S. Sternlicht
	 	 	Barry
    S. Sternlicht 
	 	 	 
	 	By:
    	/s/
    Julius Few
	 	 	Julius
    Few
	 	 	 
	 	By:
    	/s/
    Michael D. Capellas
	 	 	Michael
    D. Capellas
	 	 	 
	 	Acknowledged
    and Agreed:

 

	 	VESPER
    HEALTHCARE ACQUISITION CORP.
	 	 	 
	 	By:
    	/s/
    Brenton L. Saunders
	 	Name:	Brenton
    L. Saunders
	 	Title:	Chief
    Executive Officer

 

 

 

6Exhibit 10.2

 

September 29, 2020

 

Vesper Healthcare Acquisition Corp.

1819 West Avenue

Bay 2

Miami Beach, FL 33139

 

		Re:	Initial Public Offering

 

Ladies and Gentlemen:

 

This letter (the “Letter Agreement”)
is being delivered to you in accordance with the Underwriting Agreement (the “Underwriting Agreement”)
entered into by and between Vesper Healthcare Acquisition Corp., a Delaware corporation (the “Company”)
and Goldman Sachs & Co. LLC and J.P. Morgan Securities LLC, as representatives (the “Representatives”)
of the several underwriters named in Schedule I thereto (the “Underwriters”), relating to an underwritten
initial public offering (the “IPO”) of the Company’s units (the “Units”),
each unit comprised of one share of the Company’s Class A common stock, par value $0.0001 per share (the “Common Stock”),
and one-third of one redeemable warrant, each whole warrant exercisable for one share of Common Stock (each, a “Warrant”).
Certain capitalized terms used herein are defined in paragraph 10 hereof.

 

In order to induce the Company and the Underwriters to enter
into the Underwriting Agreement and to proceed with the IPO, and in recognition of the benefit that such IPO will confer upon the
undersigned as a stockholder of the Company, and for other good and valuable consideration, the receipt and sufficiency of which
are hereby acknowledged, the undersigned hereby agrees with the Company as follows:

 

		1.	If the Company solicits approval of its stockholders of a Business Combination, the undersigned will vote all shares of Common
Stock beneficially owned by it, whether acquired before, in or after the IPO, in favor of such Business Combination.

 

		2.	In the event that the Company does not complete a Business Combination within the time period set forth in the Company’s
second amended and restated certificate of incorporation, as the same may be further amended from time to time (the “Charter”),
the undersigned will, as promptly as possible, take all necessary actions to cause the Company to (i) cease all operations except
for the purpose of winding up, (ii) as promptly as reasonably possible, but not more than 10 business days thereafter, redeem the
IPO Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including
interest earned on the Trust Account not previously released to the Company to pay its tax obligations, if any (less up to $100,000
of such net interest to pay dissolution expenses), divided by the number of then outstanding IPO Shares, which redemption will
completely extinguish public stockholders’ rights as stockholders (including the right to receive further liquidation distributions,
if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s
remaining stockholders and the Company’s board of directors, dissolve and liquidate, subject in the cases of clauses (ii)
and (iii) to the Company’s obligations under Delaware law to provide for claims of creditors and other requirements of applicable
law. The undersigned hereby waives any and all right, title, interest or claim of any kind in or to any distribution of the Trust
Account and any remaining net assets of the Company as a result of such liquidation with respect to the Founder Shares owned by
the undersigned. However, if the undersigned has acquired IPO Shares in or after the IPO, it will be entitled to liquidating distributions
from the Trust Account with respect to such IPO Shares in the event that the Company does not complete a Business Combination within
the time period set forth in the Charter. In the event of the liquidation of the Trust Account, the undersigned agrees that it
will be liable to the Company if and to the extent any claims by a third party (other than the Company’s independent registered
public accounting firm) for services rendered or products sold to the Company, or a prospective target business with which the
Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below the lesser
of (i) $10.00 per IPO Share and (ii) the actual amount per IPO Share held in the Trust Account as of the date of the liquidation
of the Trust Account, if less than $10.00 per IPO Share due to reductions in the value of the assets in the Trust Account, in each
case less interest that may be withdrawn to pay the Company’s tax obligations, if any; provided that such liability will
not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies
held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s
obligation to indemnify the Underwriters against certain liabilities, including liabilities under the Securities Act of 1933, as
amended, pursuant to the Underwriting Agreement. The undersigned acknowledges and agrees that there will be no distribution from
the Trust Account with respect to any Warrants, all rights of which will terminate on the Company’s liquidation.

 

     

     

    

 

		3.	The undersigned acknowledges and agrees that prior to entering into a definitive agreement for a Business Combination with
a target business that is affiliated with the undersigned or any other Insiders of the Company or their affiliates, such transaction
must be approved by a majority of the Company’s independent directors and the Company must obtain an opinion from an independent
investment banking firm, which is a member of the Financial Industry Regulatory Authority, or an independent accounting firm that
such Business Combination is fair to the Company’s unaffiliated stockholders from a financial point of view.

 

		4.	Neither the undersigned nor any affiliate of the undersigned will be entitled to receive and will not accept any compensation
or other cash payment from the Company prior to, or for services rendered in order to effectuate, the completion of the Business
Combination; provided that the Company shall be allowed to make the payments set forth in the Registration Statement adjacent to
the caption “Prospectus Summary—The Offering—Limited payments to insiders.”

 

		5.	(a) The undersigned agrees that the Founder Shares may not be transferred, assigned or sold (except to certain permitted transferees
as described in the Registration Statement or herein) (the “Lockup”) until the earlier to occur of: (1) one year after
the completion of a Business Combination or (2) the date following the completion of the Company’s initial Business Combination
on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction that results in all of
the Company’s stockholders having the right to exchange their shares of Common Stock for cash, securities or other property.
Notwithstanding the foregoing, if the closing price of the Company’s Common Stock equals or exceeds $12.00 per share (as
adjusted for share splits, stock capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within
any 30-trading day period commencing at least 150 days after the Company’s initial Business Combination, the Founder Shares
will be released from the Lockup.

 

    2

     

    

 

		(b)	Notwithstanding the provisions set forth in paragraphs 5(a) and 5(c), during the period commencing on the effective date of
the Underwriting Agreement and ending 180 days after such date, the undersigned will not, without the prior written consent of
the Representatives pursuant to the Underwriting Agreement, (i) sell, offer to sell, contract or agree to sell, hypothecate, pledge,
hedge or otherwise dispose of or agree to dispose of (or enter into any transaction that is designed to, or might reasonably be
expected to, result in the disposition (whether by actual disposition or effective economic disposition due to cash settlement
or otherwise) by the undersigned or any affiliate of the undersigned or any person in privity with the undersigned or any affiliate
of the undersigned), directly or indirectly, including the filing (or participation in the filing) of a registration statement
with the Securities and Exchange Commission (the “SEC”) in respect of, or establish or increase a put equivalent position
or liquidate or decrease a call equivalent position within the meaning of Section 16 of the Securities Exchange Act of 1934, as
amended, (the “Exchange Act”) and the rules and regulations of the SEC promulgated thereunder with respect to, any
other Units, shares of Common Stock, Founder Shares or Warrants or any securities convertible into, or exercisable, or exchangeable
for, shares of Common Stock owned by it, him or her, (ii) enter into any swap or other arrangement that transfers to another, in
whole or in part, any of the economic consequences of ownership of any Units, shares of Common Stock, Founder Shares, Warrants
or any securities convertible into, or exercisable, or exchangeable for, shares of Common Stock owned by it, him or her, whether
any such transaction is to be settled by delivery of such securities, in cash or otherwise, or (iii) publicly announce any intention
to effect any transaction, including the filing of a registration statement, specified in clause (i) or (ii). The provisions of
this paragraph will not apply (i) to the transfer of Founder Shares to any independent director appointed or elected to the Company’s
board of directors before or after the IPO or (ii) if the release or waiver is effected solely to permit a transfer not for consideration
and, in each case the transferee has agreed in writing to be bound by the same terms described in this Letter Agreement to the
extent and for the duration that such terms remain in effect at the time of the transfer.

 

		(c)	The undersigned agrees that until the Company completes an initial Business Combination, the undersigned’s Private Placement
Warrants will be subject to the transfer restrictions described in the Private Placement Warrants Purchase Agreement relating to
the undersigned’s Private Placement Warrants.

 

		(d)	Notwithstanding the provisions set forth in paragraphs 5(a) and (c), transfers, assignments and sales by the undersigned of
the Founder Shares, Private Placement Warrants and shares of Common Stock issued or issuable upon the exercise of the Private Placement
Warrants or conversion of the Founder Shares are permitted (i) to the Company’s officers or directors, any affiliates or
family members of any of the Company’s officers or directors, any members or partners of the undersigned or their affiliates,
any affiliates of the undersigned, or any employees of such affiliates; (ii) in the case of an individual, by gift to a member
of the individual’s immediate family or to a trust, the beneficiary of which is a member of one of the individual’s
immediate family, an affiliate of such person or to a charitable organization; (iii) in the case of an individual, by virtue of
laws of descent and distribution upon death of the individual; (iv) in the case of an individual, pursuant to a qualified domestic
relations order; (v) by private sales or transfers made in connection with the completion of the Business Combination at prices
no greater than the price at which the Founder Shares, Private Placement Warrants or shares of Common Stock, as applicable, were
originally purchased; (vi) by virtue of the undersigned’s organizational documents upon liquidation or dissolution of the
undersigned; (vii) to the Company for no value for cancellation in connection with the completion of the Business Combination;
(viii) in the event of the Company’s liquidation prior to the completion of a Business Combination; or (ix) in the event
of completion of a liquidation, merger, share exchange or other similar transaction which results in all of the Company’s
stockholders having the right to exchange their shares of Common Stock for cash, securities or other property subsequent to the
completion of a Business Combination; provided, however, that in the case of clauses (i) through (vi) these permitted transferees
must enter into a written agreement agreeing to be bound by the restrictions herein. For the avoidance of doubt, the transfers
of Founder Shares, Private Placement Warrants and shares of Common Stock issued or issuable upon the exercise of the Private Placement
Warrants or conversion of the Founder Shares shall be permitted regardless of whether a filing under Section 16(a) of the Exchange
Act shall be required or shall be voluntarily made with respect to such transfers.

 

    3

     

    

 

		6.	The undersigned has full right and power, without violating any agreement by which it is bound, to enter into this Letter Agreement.

 

		7.	The undersigned hereby waives any right to exercise redemption rights with respect to any of the Company’s shares of
Common Stock owned or to be owned by the undersigned, directly or indirectly, whether such shares be part of the Founder Shares
or IPO Shares, and agrees not to seek redemption with respect to such shares (or sell such shares to the Company in any tender
offer) in connection with (x) the consummation of a Business Combination or (y) any stockholder vote to approve an amendment to
the Charter that would affect the substance or timing of the Company’s obligation to allow redemption in connection with
the Business Combination or to redeem 100% of the shares of Common Stock if the Company has not completed a Business Combination
within the time period set forth in the Charter or with respect to any other provisions relating to stockholders’ rights
or pre-initial business combination activity.

 

		8.	The undersigned hereby agrees to not propose, or vote in favor of, an amendment to Paragraph 25(d) of the Charter prior to
the completion of a Business Combination unless the Company provides public stockholders with the opportunity to redeem their shares
of Common Stock upon such approval in accordance with such Paragraph 25(d) thereof.

 

		9.	This Letter Agreement shall be governed by and construed and enforced in accordance with the laws of the State of New York,
without giving effect to conflicts of law principles that would result in the application of the substantive laws of another jurisdiction.
The undersigned hereby (i) agrees that any action, proceeding or claim against him arising out of or relating in any way to this
Letter Agreement shall be brought and enforced in the courts of the State of New York of the United States of America for the Southern
District of New York, and irrevocably submits to such jurisdiction, which jurisdiction shall be exclusive and (ii) waives any objection
to such exclusive jurisdiction and that such courts represent an inconvenient forum.

 

		10.	As used herein, (i) a “Business Combination” shall mean a merger, capital stock exchange, asset acquisition, stock
purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities; (ii)
“Insiders” shall mean all officers and directors, and the sponsor of the Company immediately prior to the IPO; (iii)
“Founder Shares” shall mean all of the Class B Common Stock of the Company, par value $0.0001 per share, acquired by
an Insider prior to the IPO; (iv) “IPO Shares” shall mean the shares of Common Stock issued in the Company’s
IPO; (v) “Private Placement Warrants” shall mean the warrants that are being sold privately by the Company simultaneously
with the consummation of the IPO; (vi) “Trust Account” shall mean the trust account into which the net proceeds of
the Company’s IPO and a portion of the proceeds from the sale of the Private Placement Warrants will be deposited; and (vii)
“Registration Statement” means the Company’s registration statement on Form S-1 (SEC File No. 333-248717) filed
with the SEC, as amended.

 

		11.	This Letter Agreement constitutes the entire agreement and understanding of the parties hereto in respect of the subject matter
hereof and supersedes all prior understandings, agreements, or representations by or among the parties hereto, written or oral,
to the extent they relate in any way to the subject matter hereof or the transactions contemplated hereby. This Letter Agreement
may not be changed, amended, modified or waived (other than to correct a typographical error) as to any particular provision, except
by a written instrument executed by all parties hereto.

 

		12.	The undersigned acknowledges and understands that the Underwriters and the Company will rely upon the agreements, representations
and warranties set forth herein in proceeding with the IPO. Nothing contained herein shall be deemed to render any Underwriter
a representative of, or a fiduciary with respect to, the Company, its stockholders or any creditor or vendor of the Company with
respect to the subject matter hereof.

 

		13.	This Letter Agreement shall be binding on the undersigned and such person’s respective successors, heirs, personal representatives
and assigns. This Letter Agreement shall terminate on the earlier of (i) the completion of a Business Combination and (ii) the
liquidation of the Company; provided, that such termination shall not relieve the undersigned from liability for any breach of
this agreement prior to its termination. The parties hereto may not assign either this Letter Agreement or any of their rights,
interests, or obligations hereunder without the prior written consent of the other party. Any purported assignment in violation
of this paragraph shall be void and ineffectual and shall not operate to transfer or assign any interest or title to the purported
assignee.

 

[Signature Page Follows]

 

    4

     

    

 

	 	BLS INVESTOR GROUP LLC
	 	 	 
	 	By:	/s/ Brenton L. Saunders 
	 	Name: 	Brenton L. Saunders
	 	Title:	Managing Member

 

	 	Acknowledged and Agreed:
	 	 	 
	 	VESPER HEALTHCARE ACQUISITION CORP.
	 	 	 
	 	By:	/s/ Brenton L. Saunders
	 	Name: 	Brenton L. Saunders
	 	Title:	Chief Executive Officer

 

[Signature Page to Letter Agreement (Sponsor)]

 

 

5

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00314-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00314-of-00352.parquet"}]]